A B Naini
Overview
Explore the profile of A B Naini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
615
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salviati L, Sacconi S, Murer L, Zacchello G, Franceschini L, Laverda A, et al.
Neurology
. 2005 Aug;
65(4):606-8.
PMID: 16116126
Coenzyme Q10 (CoQ10) deficiency has been associated with various clinical phenotypes, including an infantile multisystem disorder. The authors report a 33-month-old boy who presented with corticosteroid-resistant nephrotic syndrome in whom...
2.
Vila M, Segovia-Silvestre T, Gamez J, Marina A, Naini A, Meseguer A, et al.
Neurology
. 2003 Apr;
60(7):1203-5.
PMID: 12682338
Mutations in the thymidine kinase 2 (TK2) gene cause a myopathic form of the mitochondrial DNA depletion syndrome (MDS). Here, the authors report the unusual clinical, biochemical, and molecular findings...
3.
Mancuso M, Salviati L, Sacconi S, Otaegui D, Camano P, Marina A, et al.
Neurology
. 2002 Oct;
59(8):1197-202.
PMID: 12391347
Background: The mitochondrial DNA (mtDNA) depletion syndrome (MDS) is an autosomal recessive disorder of early childhood characterized by decreased mtDNA copy number in affected tissues. Recently, MDS has been linked...
4.
Przedborski S, Jackson-Lewis V, Naini A, Jakowec M, Petzinger G, Miller R, et al.
J Neurochem
. 2001 Mar;
76(5):1265-74.
PMID: 11238711
No abstract available.
5.
Desmond D, Moroney J, Lynch T, Chan S, Chin S, Shungu D, et al.
Neurology
. 1998 Sep;
51(3):844-9.
PMID: 9748037
Objective: To expand the reported phenotypic range of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Background: Despite numerous patient reports, our knowledge of the phenotypic range of...
6.
Ara J, Przedborski S, Naini A, Jackson-Lewis V, Trifiletti R, Horwitz J, et al.
Proc Natl Acad Sci U S A
. 1998 Jun;
95(13):7659-63.
PMID: 9636206
The decrement in dopamine levels exceeds the loss of dopaminergic neurons in Parkinson's disease (PD) patients and experimental models of PD. This discrepancy is poorly understood and may represent an...
7.
Kishore A, Nygaard T, de la Fuente-Fernandez R, Naini A, Schulzer M, Mak E, et al.
Neurology
. 1998 May;
50(4):1028-32.
PMID: 9566390
We tested the hypothesis that asymptomatic carriers of dopa-responsive dystonia (DRD) have increased dopamine D2 receptors in the striatum that protect them from the clinical manifestations of dopaminergic deficiency. We...
8.
Przedborski S, Donaldson D, Murphy P, Hirsch O, Lange D, Naini A, et al.
Neurodegeneration
. 1996 Mar;
5(1):57-64.
PMID: 8731383
Recent studies have implicated free radicals in the pathogenesis of amyotrophic lateral sclerosis (ALS), a fatal, paralytic disorder of motor neurons. Herein we report on measurements of erythrocyte activity of...
9.
Raftopoulos C, Dethy S, Laute M, Goldman S, Naini A, Przedborski S, et al.
Mov Disord
. 1996 Jan;
11(1):59-62.
PMID: 8771068
Concentrations of major catabolites of dopamine were followed in the ventricular cerebrospinal fluid (CSF) in five patients undergoing intracranial pressure monitoring for chronic hydrocephalus. Determinations were made every 2 h...
10.
Przedborski S, Levivier M, Raftopoulos C, Naini A, Hildebrand J
Mov Disord
. 1995 Jan;
10(1):28-36.
PMID: 7885353
Apomorphine is a dopamine receptor agonist increasingly used in the treatment of Parkinson's disease (PD). In the present study, we examined the plasma and ventricular cerebrospinal fluid (CSF) pharmacokinetics of...